ATHENA GOLD CORPORATION (AHNRF) earnings per share

Annual history
Fiscal years 2020 – 2024
USD / SHARE 5 PERIODS
Period End Diluted Filed
FY 2024 2024-12-31 $0.00 2025-04-09
FY 2023 2023-12-31 $0.00 2024-03-29
FY 2022 2022-12-31 -$0.10 2023-03-15
FY 2021 2021-12-31 -$0.20 2022-03-31
FY 2020 2020-12-31 2021-02-26
Quarterly history
Fiscal years 2011 – 2025
USD / SHARE 20 PERIODS
Period End Diluted Filed
Q3 2025 2025-09-30 $0.10 2025-11-21
Q2 2025 2025-06-30 $0.00 2025-08-29
Q1 2025 2025-03-31 $0.00 2025-06-02
Q4 2024 2024-12-31 $0.00 2025-04-09
Q3 2024 2024-09-30 $0.00 2024-11-07
Q2 2024 2024-06-30 $0.00 2024-08-14
Q1 2024 2024-03-31 $0.00 2024-05-14
Q4 2023 2023-12-31 $0.00 2024-03-29
Q3 2023 2023-09-30 $0.00 2023-11-13
Q2 2023 2023-06-30 $0.00 2023-08-14
Q1 2023 2023-03-31 $0.00 2023-05-04
Q4 2022 2022-12-31 -$0.10 2023-03-15
Q3 2022 2022-09-30 $0.00 2022-11-14
Q2 2022 2022-06-30 -$0.10 2022-08-15
Q1 2022 2022-03-31 $0.00 2022-05-09
Q4 2021 2021-12-31 -$0.10 2022-03-31
Q3 2021 2021-09-30 $0.00 2021-11-01
Q2 2021 2021-06-30 $0.00 2021-08-13
Q2 2012 2012-06-30 -$0.10 2012-09-14
Q2 2011 2011-06-30 $0.00 2011-09-13

Methodology

Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (1 split since 2026).

For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.

AHNRF CIK 0001304409 Source: EDGAR filings · all facts

Related tickers

AMRX

Amneal Pharmaceuticals, Inc.

GNRC

GENERAC HOLDINGS INC.

PSFE

Paysafe Ltd